BIOMAT Database Logo BIOMAT Database Logo

Conversion to cyclosporine microemulsion (Neoral) in stable renal transplant patients: results from a single center. 1998

M Cossu, and R Satta, and G F Branca, and P G Pala, and G Serra, and R P Satta, and G Sorba
Nephrology and Transplantation Unit, Sassari Hospital, Italy.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M Cossu, and R Satta, and G F Branca, and P G Pala, and G Serra, and R P Satta, and G Sorba
Conversion to microemulsion cyclosporine in stable renal transplant patients: results after one year.
May 1996, Clinical nephrology,
M Cossu, and R Satta, and G F Branca, and P G Pala, and G Serra, and R P Satta, and G Sorba
Conversion from cyclosporine Sandimmune to cyclosporine Neoral in the stable renal transplant population.
January 1997, Transplantation proceedings,
M Cossu, and R Satta, and G F Branca, and P G Pala, and G Serra, and R P Satta, and G Sorba
Conversion from the conventional cyclosporine formulation (Sandimmune) to a new oral microemulsion (Neoral) in stable liver transplant patients.
August 1998, Transplantation proceedings,
M Cossu, and R Satta, and G F Branca, and P G Pala, and G Serra, and R P Satta, and G Sorba
Safety of conversion from cyclosporine Sandimmune to cyclosporine Neoral in stable liver transplant patients.
August 1998, Transplantation proceedings,
M Cossu, and R Satta, and G F Branca, and P G Pala, and G Serra, and R P Satta, and G Sorba
A randomized prospective study of the conversion from cyclosporine to microemulsion form cyclosporine in stable renal transplant patients.
November 1998, Transplantation proceedings,
M Cossu, and R Satta, and G F Branca, and P G Pala, and G Serra, and R P Satta, and G Sorba
Conversion from Sandimmune to Neoral in stable renal and pancreas transplant recipients enhances cyclosporine absorption.
August 1996, Transplantation proceedings,
M Cossu, and R Satta, and G F Branca, and P G Pala, and G Serra, and R P Satta, and G Sorba
Pharmacokinetics and renal function after conversion from standard to microemulsion formulation of cyclosporine in stable renal transplant patients.
August 1998, Transplantation proceedings,
M Cossu, and R Satta, and G F Branca, and P G Pala, and G Serra, and R P Satta, and G Sorba
Conversion from once-daily Sandimmune cyclosporine to once-daily Neoral in renal transplant patients.
November 2000, Transplantation proceedings,
M Cossu, and R Satta, and G F Branca, and P G Pala, and G Serra, and R P Satta, and G Sorba
Conversion from Sandimmun to Neoral in stable pediatric renal transplant recipients.
April 1998, Pediatric nephrology (Berlin, Germany),
M Cossu, and R Satta, and G F Branca, and P G Pala, and G Serra, and R P Satta, and G Sorba
Neoral dose adjustment after conversion from C0 to C2 monitoring in stable renal transplant recipients: a prospective single center study.
January 2004, Journal of nephrology,
Copied contents to your clipboard!